|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ahmad S, Qureshi AN, Kazmi A, Rasool A,
Gul M, Ashfaq M, Batool L, Rehman RA, Ahmad J and Muniba: First
cancer statistics report from Hazara division. J Ayub Med Coll
Abbottabad. 25:71–73. 2013.
|
|
3
|
Bradley A, Zheng H, Ziebarth A, Sakati W,
Branham-O'Connor M, Blumer JB, Liu Y, Kistner-Griffin E,
Rodriguez-Aguayo C, Lopez-Berestein G, et al: EDD enhances cell
survival and cisplatin resistance and is a therapeutic target for
epithelial ovarian cancer. Carcinogenesis. 35:1100–1109. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cortés-Sempere M, de Miguel MP, Pernia O,
Rodriguez C, de Castro Carpeño J, Nistal M, Conde E, López-Ríos F,
Belda-Iniesta C, Perona R and Ibanez de Caceres I: IGFBP-3
methylation-derived deficiency mediates the resistance to cisplatin
through the activation of the IGFIR/Akt pathway in non-small cell
lung cancer. Oncogene. 32:1274–1283. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zeller C, Dai W, Steele NL, Siddiq A,
Walley AJ, Wilhelm-Benartzi CS, Rizzo S, van der Zee A, Plumb JA
and Brown R: Candidate DNA methylation drivers of acquired
cisplatin resistance in ovarian cancer identified by methylome and
expression profiling. Oncogene. 31:4567–4576. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gebhard C, Benner C, Ehrich M,
Schwarzfischer L, Schilling E, Klug M, Dietmaier W, Thiede C,
Holler E, Andreesen R and Rehli M: General transcription factor
binding at CpG islands in normal cells correlates with resistance
to de novo DNA methylation in cancer cells. Cancer Res.
70:1398–1407. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nojima M, Maruyama R, Yasui H, Suzuki H,
Maruyama Y, Tarasawa I, Sasaki Y, Asaoku H, Sakai H, Hayashi T, et
al: Genomic screening for genes silenced by DNA methylation
revealed an association between RASD1 inactivation and
dexamethasone resistance in multiple myeloma. Clin Cancer Res.
15:4356–4364. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Du J and Zhang L: Integrated analysis of
DNA methylation and microRNA regulation of the lung adenocarcinoma
transcriptome. Oncol Rep. 34:585–594. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kwon MJ and Shin YK: Epigenetic regulation
of cancer-associated genes in ovarian cancer. Int J Mol Sci.
12:983–1008. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sui C, Meng F, Li Y and Jiang Y: miR-148b
reverses cisplatin-resistance in non-small cell cancer cells via
negatively regulating DNA (cytosine-5)-methyltransferase 1(DNMT1)
expression. J Transl Med. 13:1322015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fumagalli C, Della Pasqua S, Bagnardi V,
Cardillo A, Sporchia A, Colleoni M, Viale G, Barberis M and Pruneri
G: Prevalence and clinicopathologic correlates of
O′-methylguanine-DNA methyltransferase methylation status in
patients with triple-negative breast cancer treated preoperatively
by alkylating drugs. Clin Breast Cancer. 14:285–290. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lin RK, Wu CY, Chang JW, Juan LJ, Hsu HS,
Chen CY, Lu YY, Tang YA, Yang YC, Yang PC and Wang YC:
Dysregulation of p53/Sp1 control leads to DNA methyltransferase-1
overexpression in lung cancer. Cancer Res. 70:5807–5817. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Qin T, Jelinek J, Si J, Shu J and Issa JP:
Mechanisms of resistance to 5-aza-2′-deoxycytidine in human cancer
cell lines. Blood. 113:659–667. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lewis BP, Burge CB and Bartel DP:
Conserved seed pairing, often flanked by adenosines, indicates that
thousands of human genes are microRNA targets. Cell. 120:15–20.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Friedman RC, Farh KK, Burge CB and Bartel
DP: Most mammalian mRNAs are conserved targets of microRNAs. Genome
Res. 19:92–105. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lynch SM, O'Neill KM, McKenna MM, Walsh CP
and McKenna DJ: Regulation of miR-200c and miR-141 by methylation
in prostate cancer. Prostate. 76:1146–1159. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu S, Liu Z, Xie Z, Pang J, Yu J, Lehmann
E, Huynh L, Vukosavljevic T, Takeki M, Klisovic RB, et al:
Bortezomib induces DNA hypomethylation and silenced gene
transcription by interfering with Sp1/NF-kappaB-dependent DNA
methyltransferase activity in acute myeloid leukemia. Blood.
111:2364–2373. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yang H, Ou CC, Feldman RI, Nicosia SV,
Kruk PA and Cheng JQ: Aurora-A kinase regulates telomerase activity
through c-Myc in human ovarian and breast epithelial cells. Cancer
Res. 64:463–467. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tang H, Wang Z, Liu X, Liu Q, Xu G, Li G
and Wu M: LRRC4 inhibits glioma cell growth and invasion through a
miR-185-dependent pathway. Curr Cancer Drug Targets. 12:1032–1042.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yang L, Tang H, Kong Y and Xie X, Chen J,
Song C, Liu X, Ye F, Li N, Wang N and Xie X: LGR5 promotes breast
cancer progression and maintains stem-like cells through activation
of Wnt/β-catenin signaling. Stem Cells. 33:2913–2924. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ding W, Dang H, You H, Steinway S,
Takahashi Y, Wang HG, Liao J, Stiles B, Albert R and Rountree CB:
miR-200b restoration and DNA methyltransferase inhibitor block lung
metastasis of mesenchymal-phenotype hepatocellular carcinoma.
Oncogenesis. 1:e152012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tang H, Deng M, Tang Y and Xie X, Guo J,
Kong Y, Ye F, Su Q and Xie X: miR-200b and miR-200c as prognostic
factors and mediators of gastric cancer cell progression. Clin
Cancer Res. 19:5602–5612. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Stathopoulos GP: Cisplatin: Process and
future. J BUON. 18:564–569. 2013.PubMed/NCBI
|
|
26
|
Roossink F, de Jong S, Wisman GB, van der
Zee AG and Schuuring E: DNA hypermethylation biomarkers to predict
response to cisplatin treatment, radiotherapy or chemoradiation:
The present state of art. Cell Oncol (Dordr). 35:231–241. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kelland L: The resurgence of
platinum-based cancer chemotherapy. Nat Rev Cancer. 7:573–584.
2007. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Helleday T, Petermann E, Lundin C, Hodgson
B and Sharma RA: DNA repair pathways as targets for cancer therapy.
Nat Rev Cancer. 8:193–204. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
29
|
O'Grady S, Finn SP, Cuffe S, Richard DJ,
O'Byrne KJ and Barr MP: The role of DNA repair pathways in
cisplatin resistant lung cancer. Cancer Treat Rev. 40:1161–1170.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Weis B, Schmidt J, Maamar H, Raj A, Lin H,
Tóth C, Riedmann K, Raddatz G, Seitz HK, Ho AD, et al: Inhibition
of intestinal tumor formation by deletion of the DNA
methyltransferase 3a. Oncogene. 34:1822–1830. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liu B, Wang Z, Zhang L, Ghosh S, Zheng H
and Zhou Z: Depleting the methyltransferase Suv39h1 improves DNA
repair and extends lifespan in a progeria mouse model. Nat Commun.
4:18682013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hayette S, Thomas X, Jallades L, Chabane
K, Charlot C, Tigaud I, Gazzo S, Morisset S, Cornillet-Lefebvre P,
Plesa A, et al: High DNA methyltransferase DNMT3B levels: A poor
prognostic marker in acute myeloid leukemia. PLoS One.
7:e515272012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Fabbri M, Garzon R, Cimmino A, Liu Z,
Zanesi N, Callegari E, Liu S, Alder H, Costinean S,
Fernandez-Cymering C, et al: MicroRNA-29 family reverts aberrant
methylation in lung cancer by targeting DNA methyltransferases 3A
and 3B. Proc Natl Acad Sci USA. 104:15805–15810. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hur K, Toiyama Y, Takahashi M, Balaguer F,
Nagasaka T, Koike J, Hemmi H, Koi M, Boland CR and Goel A:
MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT)
in human colorectal cancer metastasis. Gut. 62:1315–1326. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Burk U, Schubert J, Wellner U, Schmalhofer
O, Vincan E, Spaderna S and Brabletz T: A reciprocal repression
between ZEB1 and members of the miR-200 family promotes EMT and
invasion in cancer cells. EMBO Rep. 9:582–589. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Park SM, Gaur AB, Lengyel E and Peter ME:
The miR-200 family determines the epithelial phenotype of cancer
cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes
Dev. 22:894–907. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Gregory PA, Bert AG, Paterson EL, Barry
SC, Tsykin A, Farshid G, Vadas MA, Khew-Goodall Y and Goodall GJ:
The miR-200 family and miR-205 regulate epithelial to mesenchymal
transition by targeting ZEB1 and SIP1. Nat Cell Biol. 10:593–601.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
38
|
Bracken CP, Gregory PA, Kolesnikoff N,
Bert AG, Wang J, Shannon MF and Goodall GJ: A double-negative
feedback loop between ZEB1-SIP1 and the microRNA-200 family
regulates epithelial-mesenchymal transition. Cancer Res.
68:7846–7854. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kishikawa S, Murata T, Kimura H, Shiota K
and Yokoyama KK: Regulation of transcription of the Dnmt1 gene by
Sp1 and Sp3 zinc finger proteins. Eur J Biochem. 269:2961–2970.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Cicalese A, Bonizzi G, Pasi CE, Faretta M,
Ronzoni S, Giulini B, Brisken C, Minucci S, Di Fiore PP and Pelicci
PG: The tumor suppressor p53 regulates polarity of self-renewing
divisions in mammary stem cells. Cell. 138:1083–1095. 2009.
View Article : Google Scholar : PubMed/NCBI
|
